Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Apr;108(4):980–990. doi: 10.1111/j.1476-5381.1993.tb13495.x

Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.

P Arvola 1, H Ruskoaho 1, H Wuorela 1, A Pekki 1, H Vapaatalo 1, I Pörsti 1
PMCID: PMC1908145  PMID: 8485636

Abstract

1 The effects of long-term angiotensin-converting enzyme inhibition with quinapril on arterial function were studied in spontaneously hypertensive rats, Wistar-Kyoto rats serving as normotensive controls. 2 Adult hypertensive animals were treated with quinapril (10 mg kg-1 day-1) for 15 weeks, which reduced their blood pressure and the concentrations of atrial natriuretic peptide in plasma and ventricular tissue to a level comparable with that in normotensive rats. 3 Responses of mesenteric arterial rings in vitro were examined at the end of the study. Compared with normotensive and untreated hypertensive rats, responses to noradrenaline were attenuated in hypertensive animals on quinapril, both force of contraction and sensitivity being reduced. Quinapril also attenuated maximal contractions but not sensitivity to potassium chloride. Nifedipine less effectively inhibited vascular contractions in normotensive and quinapril-treated than in untreated hypertensive rats. 4 Arterial relaxation responses by endothelium-dependent (acetylcholine) and endothelium-independent (sodium nitrite, isoprenaline) mechanisms were similar in normotensive and quinapril-treated rats and more pronounced than in untreated hypertensive rats. 5 Cell membrane permeability to ions was evaluated by means of potassium-free solution-induced contractions of endothelium-denuded denervated arterial rings. These responses were comparable in normotensive and quinapril-treated rats and less marked than in untreated hypertensive rats. 6 Intracellular free calcium concentrations in platelets and lymphocytes, measured by the fluorescent indicator quin-2, were similar in normotensive and quinapril-treated rats and lower than in untreated hypertensive rats. 7 In conclusion, quinapril treatment improved relaxation responses and attenuated contractions in arterial smooth muscle of hypertensive rats. These changes may be explained by diminished cytosolic free calcium concentration, reduced cell membrane permeability, and alterations in dihydropyridine-sensitive calcium channels following long-term angiotensin-converting enzyme inhibition.

Full text

PDF
985

Images in this article

987Figure 7
on p.987

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M. A., Bobik A., Korner P. I. Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension. 1990 Sep;16(3):252–260. doi: 10.1161/01.hyp.16.3.252. [DOI] [PubMed] [Google Scholar]
  2. Aprigliano O., Hermsmeyer K. In vitro denervation of the portal vein and caudal artery of the rat. J Pharmacol Exp Ther. 1976 Sep;198(3):568–577. [PubMed] [Google Scholar]
  3. Arai H., Nakao K., Saito Y., Morii N., Sugawara A., Yamada T., Itoh H., Shiono S., Mukoyama M., Ohkubo H. Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone. Circ Res. 1988 May;62(5):926–930. doi: 10.1161/01.res.62.5.926. [DOI] [PubMed] [Google Scholar]
  4. Arvola P., Pörsti I., Vuorinen P., Pekki A., Vapaatalo H. Contractions induced by potassium-free solution and potassium relaxation in vascular smooth muscle of hypertensive and normotensive rats. Br J Pharmacol. 1992 May;106(1):157–165. doi: 10.1111/j.1476-5381.1992.tb14309.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baudin B., Drouet L. In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells. J Cardiovasc Pharmacol. 1989;14 (Suppl 4):S37–S42. [PubMed] [Google Scholar]
  6. Bean B. P., Sturek M., Puga A., Hermsmeyer K. Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs. Circ Res. 1986 Aug;59(2):229–235. doi: 10.1161/01.res.59.2.229. [DOI] [PubMed] [Google Scholar]
  7. Bonaccorsi A., Hermsmeyer K., Aprigliano O., Smith C. B., Bohr D. F. Mechanism of potassium relaxation of arterial muscle. Blood Vessels. 1977;14(5):261–276. doi: 10.1159/000158133. [DOI] [PubMed] [Google Scholar]
  8. Bund S. J., West K. P., Heagerty A. M. Effects of protection from pressure on resistance artery morphology and reactivity in spontaneously hypertensive and Wistar-Kyoto rats. Circ Res. 1991 May;68(5):1230–1240. doi: 10.1161/01.res.68.5.1230. [DOI] [PubMed] [Google Scholar]
  9. Caldwell P. R., Seegal B. C., Hsu K. C., Das M., Soffer R. L. Angiotensin-converting enzyme: vascular endothelial localization. Science. 1976 Mar 12;191(4231):1050–1051. doi: 10.1126/science.175444. [DOI] [PubMed] [Google Scholar]
  10. Clozel M., Kuhn H., Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990 Nov;16(5):532–540. doi: 10.1161/01.hyp.16.5.532. [DOI] [PubMed] [Google Scholar]
  11. Dohi Y., Hahn A. W., Boulanger C. M., Bühler F. R., Lüscher T. F. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 1992 Feb;19(2):131–137. doi: 10.1161/01.hyp.19.2.131. [DOI] [PubMed] [Google Scholar]
  12. Freslon J. L., Giudicelli J. F. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol. 1983 Nov;80(3):533–543. doi: 10.1111/j.1476-5381.1983.tb10726.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Furspan P. B., Rinaldi G. J., Hoffman K., Bohr D. F. Dietary calcium and cell membrane abnormality in genetic hypertension. Hypertension. 1989 Jun;13(6 Pt 2):727–730. doi: 10.1161/01.hyp.13.6.727. [DOI] [PubMed] [Google Scholar]
  14. Guicheney P., Wauquier I., Paquet J. L., Meyer P. Enhanced response to growth factors and to angiotensin II of spontaneously hypertensive rat skin fibroblasts in culture. J Hypertens. 1991 Jan;9(1):23–27. [PubMed] [Google Scholar]
  15. Harrap S. B., Van der Merwe W. M., Griffin S. A., Macpherson F., Lever A. F. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990 Dec;16(6):603–614. doi: 10.1161/01.hyp.16.6.603. [DOI] [PubMed] [Google Scholar]
  16. Johns A., Leijten P., Yamamoto H., Hwang K., van Breemen C. Calcium regulation in vascular smooth muscle contractility. Am J Cardiol. 1987 Jan 23;59(2):18A–23A. doi: 10.1016/0002-9149(87)90171-8. [DOI] [PubMed] [Google Scholar]
  17. Johnson M. L., Ely D. L., Turner M. E. Genetic divergence between the Wistar-Kyoto rat and the spontaneously hypertensive rat. Hypertension. 1992 May;19(5):425–427. doi: 10.1161/01.hyp.19.5.425. [DOI] [PubMed] [Google Scholar]
  18. Kaplan H. R., Cohen D. M., Essenburg A. D., Major T. C., Mertz T. E., Ryan M. J. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors. Fed Proc. 1984 Apr;43(5):1326–1329. [PubMed] [Google Scholar]
  19. Karaki H., Weiss G. B. Calcium release in smooth muscle. Life Sci. 1988;42(2):111–122. doi: 10.1016/0024-3205(88)90674-1. [DOI] [PubMed] [Google Scholar]
  20. Kinnunen P., Taskinen T., Järvinen M., Ruskoaho H. Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium. Br J Pharmacol. 1991 Feb;102(2):453–461. doi: 10.1111/j.1476-5381.1991.tb12194.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kinnunen P., Taskinen T., Leppäluoto J., Ruskoaho H. Release of atrial natriuretic peptide from rat myocardium in vitro: effect of minoxidil-induced hypertrophy. Br J Pharmacol. 1990 Apr;99(4):701–708. doi: 10.1111/j.1476-5381.1990.tb12992.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kurtz T. W., Simonet L., Kabra P. M., Wolfe S., Chan L., Hjelle B. L. Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. J Clin Invest. 1990 Apr;85(4):1328–1332. doi: 10.1172/JCI114572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lee R. M., Berecek K. H., Tsoporis J., McKenzie R., Triggle C. R. Prevention of hypertension and vascular changes by captopril treatment. Hypertension. 1991 Feb;17(2):141–150. doi: 10.1161/01.hyp.17.2.141. [DOI] [PubMed] [Google Scholar]
  24. Levy B. I., Benessiano J., Poitevin P., Safar M. E. Endothelium-dependent mechanical properties of the carotid artery in WKY and SHR. Role of angiotensin converting enzyme inhibition. Circ Res. 1990 Feb;66(2):321–328. doi: 10.1161/01.res.66.2.321. [DOI] [PubMed] [Google Scholar]
  25. Malini P. L., Strocchi E., Valtancoli G., Ambrosioni E. ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients. J Clin Pharmacol. 1990 May;30(5):422–424. doi: 10.1002/j.1552-4604.1990.tb03480.x. [DOI] [PubMed] [Google Scholar]
  26. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  27. Morris B. J. Molecular genetics links renin to hypertension. Mol Cell Endocrinol. 1991 Feb;75(2):C13–C18. doi: 10.1016/0303-7207(91)90221-d. [DOI] [PubMed] [Google Scholar]
  28. Mulvany M. J. Changes in sodium pump activity and vascular contraction. J Hypertens. 1985 Oct;3(5):429–436. [PubMed] [Google Scholar]
  29. Mulvany M. J., Nyborg N. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br J Pharmacol. 1980;71(2):585–596. doi: 10.1111/j.1476-5381.1980.tb10977.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mulvany M. J., Persson A. E., Andresen J. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J Hypertens. 1991 Jul;9(7):589–593. doi: 10.1097/00004872-199107000-00002. [DOI] [PubMed] [Google Scholar]
  31. Oshima T., Young E. W., McCarron D. A. Abnormal platelet and lymphocyte calcium handling in prehypertensive rats. Hypertension. 1991 Jul;18(1):111–115. doi: 10.1161/01.hyp.18.1.111. [DOI] [PubMed] [Google Scholar]
  32. Paquet J. L., Baudouin-Legros M., Marche P., Meyer P. Enhanced proliferating activity of cultured smooth muscle cells from SHR. Am J Hypertens. 1989 Feb;2(2 Pt 1):108–110. doi: 10.1093/ajh/2.2.108. [DOI] [PubMed] [Google Scholar]
  33. Pörsti I. Arterial smooth muscle contractions in spontaneously hypertensive rats on a high-calcium diet. J Hypertens. 1992 Mar;10(3):255–263. [PubMed] [Google Scholar]
  34. Pörsti I., Arvola P., Wuorela H., Vapaatalo H. High calcium diet augments vascular potassium relaxation in hypertensive rats. Hypertension. 1992 Jan;19(1):85–92. doi: 10.1161/01.hyp.19.1.85. [DOI] [PubMed] [Google Scholar]
  35. Rusch N. J., Hermsmeyer K. Calcium currents are altered in the vascular muscle cell membrane of spontaneously hypertensive rats. Circ Res. 1988 Dec;63(6):997–1002. doi: 10.1161/01.res.63.6.997. [DOI] [PubMed] [Google Scholar]
  36. Ruskoaho H., Kinnunen P., Taskinen T., Vuolteenaho O., Leppäluoto J., Takala T. E. Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium. Effects of exercise. Circulation. 1989 Aug;80(2):390–400. doi: 10.1161/01.cir.80.2.390. [DOI] [PubMed] [Google Scholar]
  37. Ruskoaho H., Leppäluoto J. Immunoreactive atrial natriuretic peptide in ventricles, atria, hypothalamus, and plasma of genetically hypertensive rats. Circ Res. 1988 Feb;62(2):384–394. doi: 10.1161/01.res.62.2.384. [DOI] [PubMed] [Google Scholar]
  38. Sada T., Koike H., Ikeda M., Sato K., Ozaki H., Karaki H. Cytosolic free calcium of aorta in hypertensive rats. Chronic inhibition of angiotensin converting enzyme. Hypertension. 1990 Sep;16(3):245–251. doi: 10.1161/01.hyp.16.3.245. [DOI] [PubMed] [Google Scholar]
  39. Schrör K. Converting enzyme inhibitors and the interaction between kinins and eicosanoids. J Cardiovasc Pharmacol. 1990;15 (Suppl 6):S60–S68. [PubMed] [Google Scholar]
  40. St Lezin E., Simonet L., Pravenec M., Kurtz T. W. Hypertensive strains and normotensive 'control' strains. How closely are they related? Hypertension. 1992 May;19(5):419–424. doi: 10.1161/01.hyp.19.5.419. [DOI] [PubMed] [Google Scholar]
  41. Stull J. T., Gallagher P. J., Herring B. P., Kamm K. E. Vascular smooth muscle contractile elements. Cellular regulation. Hypertension. 1991 Jun;17(6 Pt 1):723–732. doi: 10.1161/01.hyp.17.6.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sugiyama T., Yoshizumi M., Takaku F., Yazaki Y. Abnormal calcium handling in vascular smooth muscle cells of spontaneously hypertensive rats. J Hypertens. 1990 Apr;8(4):369–375. doi: 10.1097/00004872-199004000-00011. [DOI] [PubMed] [Google Scholar]
  43. Säynävälammi P., Pörsti I., Nurmi A. K., Seppälä E., Metsä-Ketelä T., Tuomisto L., Manninen V., Vapaatalo H. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1986 Apr;237(1):246–251. [PubMed] [Google Scholar]
  44. Tsien R. Y., Pozzan T., Rink T. J. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J Cell Biol. 1982 Aug;94(2):325–334. doi: 10.1083/jcb.94.2.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Vane J. R., Anggård E. E., Botting R. M. Regulatory functions of the vascular endothelium. N Engl J Med. 1990 Jul 5;323(1):27–36. doi: 10.1056/NEJM199007053230106. [DOI] [PubMed] [Google Scholar]
  46. Waeber B., Nussberger J., Juillerat L., Brunner H. R. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity. J Cardiovasc Pharmacol. 1989;14 (Suppl 4):S53–S59. [PubMed] [Google Scholar]
  47. Wiemer G., Schölkens B. A., Becker R. H., Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991 Oct;18(4):558–563. doi: 10.1161/01.hyp.18.4.558. [DOI] [PubMed] [Google Scholar]
  48. Xiao X. H., Rand M. J. Mechanisms of vasoconstrictor responses to KCl in rat isolated perfused tail arteries: interaction with the alpha 2-adrenoceptor agonist UK14304. Eur J Pharmacol. 1991 Apr 17;196(2):133–136. doi: 10.1016/0014-2999(91)90418-p. [DOI] [PubMed] [Google Scholar]
  49. Young E. W., Bukoski R. D., McCarron D. A. Calcium metabolism in experimental hypertension. Proc Soc Exp Biol Med. 1988 Feb;187(2):123–141. doi: 10.3181/00379727-187-42646. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES